Qoolabs
Qoolabs is a biotechnology company specializing in the development and production of monoclonal antibodies, with a focus on rabbit antibodies for research, diagnostic, and therapeutic drug development. The company uses an advanced antibody discovery platform capable of rapidly generating highly specific and sensitive antibodies from various species. Qoolabs is committed to innovation and quality, maintaining ISO17025 laboratory accreditation and a strong record of securing grant funding and delivering advanced antibody-based solutions.
Industries
N/A
Products
Monoclonal antibodies against diverse targets, including viral antigens (HCV, HBV, SARS-CoV-2), guinea pig cytokines, and other antigens; validated for various applications.
Single-step, quick-read lateral flow tests for protein or epitope tag detection, using validated recombinant antibodies.
Array of purified proteins for research, including control proteins for epitope tags and species-specific cytokines.
Buffers and ELISA kits for antigen and antibody detection, validated for high performance.
Monoclonal antibodies against diverse targets, including viral antigens (HCV, HBV, SARS-CoV-2), guinea pig cytokines, and other antigens; validated for various applications.
Single-step, quick-read lateral flow tests for protein or epitope tag detection, using validated recombinant antibodies.
Array of purified proteins for research, including control proteins for epitope tags and species-specific cytokines.
Buffers and ELISA kits for antigen and antibody detection, validated for high performance.
Services
Custom generation of monoclonal antibodies from peripheral blood B cells, including rabbits, chickens, and llamas, with options for specificity and challenging targets.
Production and purification of recombinant antibodies in mammalian cells at laboratory scale or larger quantities under ISO 17025 accreditation.
Improvement of antibody characteristics via affinity maturation, humanization, and stable cell line generation.
Custom generation of monoclonal antibodies from peripheral blood B cells, including rabbits, chickens, and llamas, with options for specificity and challenging targets.
Production and purification of recombinant antibodies in mammalian cells at laboratory scale or larger quantities under ISO 17025 accreditation.
Improvement of antibody characteristics via affinity maturation, humanization, and stable cell line generation.
Expertise Areas
- Monoclonal antibody development
- Antibody engineering
- Affinity and specificity screening
- Immunoassay development
Key Technologies
- Antibody cloning from peripheral blood B cells
- Mammalian cell expression systems
- Single-cell interrogation for antibody pairing
- Epitope-specific screening
News & Updates
Awarded SBIR grants and contracts for affinity reagent development, rapid diagnostic tests, and advanced immunoassays.
Accredited as an ISO 17025 laboratory for antibody engineering and analytical services.
Booth presence at the AACR Annual Meeting 2026 in San Diego (Booth 4454), featuring flyers on rapid tests and antibody discovery for guinea pig and hamster.
Awarded SBIR grants and contracts for affinity reagent development, rapid diagnostic tests, and advanced immunoassays.
Accredited as an ISO 17025 laboratory for antibody engineering and analytical services.
Booth presence at the AACR Annual Meeting 2026 in San Diego (Booth 4454), featuring flyers on rapid tests and antibody discovery for guinea pig and hamster.